Holtec Delays Palisades Nuclear Restart Despite DOE Support

Holtec International has delayed the Palisades nuclear restart beyond its October 2025 target, according to ZeroHedge, despite completing major refurbishment projects and securing a $1.5 billion Department of Energy loan. The company now states the plant will restart "when the plant is ready for long-term operations," with CEO Kris Singh telling the Financial Times he still expects the plant back this year, ahead of the March 2027 power supply contract. The repeated schedule shifts raise questions about reactor restart execution risk and the industry argument that restarts represent the lowest-risk, fastest path to new nuclear capacity.

Key takeaways
Holtec completed major refurbishment projects at Palisades, including reactor vessel inspections, head penetration replacements, steam generator tube refurbishment, primary system decontamination, and operator training, with new fuel now on site.
The company has shifted from an October 2025 restart target to the vaguer statement that Palisades will restart "when the plant is ready for long-term operations," with more than 5,000 individual work activities remaining on the checklist.
A federal court dismissed the environmental groups' lawsuit challenging the NRC exemption that allows a decommissioned plant to restart, and Holtec is preparing an IPO that multiple outlets peg at a roughly $10 billion valuation.
The repeated movement of internal targets undercuts the core industry argument that restarts represent the lowest-risk, fastest path to new nuclear capacity, making reactor restarts look more uncertain and execution-heavy than building a new plant from scratch.

Table of Contents
What happened
Refurbishment progress and remaining work
Schedule evolution and current timeline
Legal and financial developments
Why execution risk matters for nuclear restarts
What to watch next

What happened

Holtec International announced last week that major refurbishment projects at Palisades are complete, according to ZeroHedge. Reactor vessel inspections, head penetration replacements, steam generator tube refurbishment, primary system decontamination, and operator training all wrapped up. New fuel now sits on site, ready for loading. The company called it a "watershed moment" and shifted focus to grinding through the remaining work. Yet there is still no restart date.

Holtec International Director of Government Affairs and Communications Patrick O'Brien told Utility Dive in 2025 that the company "remains on track to restart operations at Palisades in October 2025." That date has passed. Starting earlier this year, the company pivoted to the vaguer line that Palisades would restart "when the plant is ready for long-term operations." CEO Kris Singh told the Financial Times he still expects the plant back this year, ahead of the March 2027 power supply contract. But "this year" is now half over with no firm schedule attached.

Refurbishment progress and remaining work

The completion of major refurbishment projects represents a significant milestone for Holtec. Reactor vessel inspections, head penetration replacements, steam generator tube refurbishment, primary system decontamination, and operator training are complex, capital-intensive activities that require specialized expertise and regulatory oversight. The fact that new fuel now sits on site, ready for loading, indicates that Holtec has moved through the most technically demanding phases of the restart process.

However, more than 5,000 individual work activities remain on the checklist, according to the source context. Most are described as routine maintenance, testing, inspection, and operational readiness items. For investors and industry observers, the gap between major refurbishment completion and full operational readiness illustrates the execution complexity of reactor restarts. Even after the most visible technical milestones are achieved, the remaining work can be time-consuming and difficult to schedule with precision.

Schedule evolution and current timeline

When the $1.5 billion DOE loan closed in 2024, expectations centered on a late 2025 restart, according to ZeroHedge. As the first deadline came to pass near the end of 2025 and the beginning of 2026, material issues, particularly with steam generators, had pushed the target into the middle of 2026. Each update added a few more months. Now the language has softened further into "steady progress" and "when ready."

The repeated movement of internal targets is notable because Palisades was always presented as the easiest restart project on the table. An existing plant on an existing site, with a recently operating license framework, the first major DOE loan guarantee, and novel NRC regulatory pathways created specifically to enable it. If any restart should have translated funding, approvals, and major refurbishment work into electrons on the grid without prolonged slippage, this was the one. The current shift to "when the plant is ready for long-term operations" instead makes reactor restarts look more uncertain and execution-heavy than simply licensing and building a new plant from scratch.

Legal and financial developments

The legal and financial pieces have at least moved forward, according to the source context. A federal court dismissed the environmental groups' lawsuit challenging the NRC exemption that allows a decommissioned plant to restart. This removes a significant regulatory and legal uncertainty that could have delayed or derailed the project. The dismissal of the lawsuit provides Holtec with a clearer path to restart operations without the risk of further legal challenges on this specific issue.

Holtec is also preparing an IPO that multiple outlets peg at a roughly $10 billion valuation, according to ZeroHedge. For investors, the IPO preparation indicates that Holtec is positioning itself as a publicly traded company with a business model that includes reactor restarts as a core component. The $10 billion valuation, if accurate, suggests that capital markets are willing to assign significant value to Holtec's nuclear restart capabilities, despite the execution challenges at Palisades. However, the repeated schedule delays may influence investor perception of execution risk and the company's ability to deliver on restart timelines.

Why execution risk matters for nuclear restarts

The repeated movement of internal targets and the current shift to "when the plant is ready for long-term operations" undercuts the core industry argument that restarts represent the lowest-risk, fastest path to new nuclear capacity, according to the source context. For investors and policymakers evaluating nuclear energy as a clean energy solution, the Palisades experience provides a real-world case study in the execution complexity of reactor restarts. The project had significant advantages: an existing plant on an existing site, a recently operating license framework, the first major DOE loan guarantee, and novel NRC regulatory pathways created specifically to enable it.

If Palisades, with all these advantages, has experienced prolonged schedule slippage, it raises questions about the execution risk of other reactor restart projects that may lack the same level of regulatory support, financial backing, or technical readiness. For readers following broader market updates , the Palisades delays illustrate the gap between policy support and operational execution in the nuclear energy sector. The DOE loan guarantee, the NRC exemption, and the completion of major refurbishment projects are all necessary conditions for a successful restart, but they may not be sufficient to ensure that the project meets its original timeline.

What to watch next

Market readers and energy investors should watch for future Holtec disclosures on the remaining 5,000 work activities and any updated restart timeline. The company has shifted to the language of "when the plant is ready for long-term operations," which suggests that internal scheduling has become more difficult to predict with precision. Any future updates that provide a firm restart date, or that explain the specific technical or regulatory challenges driving the delays, would be useful for assessing execution risk.

Readers should also monitor the Holtec IPO process and any public disclosures that accompany it. If Holtec proceeds with an IPO at a roughly $10 billion valuation, the company will be required to provide detailed financial and operational disclosures that may shed light on the Palisades restart timeline, the remaining work activities, and the company's broader business model. The IPO disclosures may also provide insight into how Holtec is managing the execution risk of reactor restarts and how it plans to apply lessons learned from Palisades to other potential restart projects.

Read original source